#SFHS2615243AFrance renews reimbursement coverage for LAO’s SPOT scleral lens
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The order renews and updates reimbursement conditions for LAO’s SPOT oxygen-permeable scleral lens under France’s reimbursable medical products list. The device is a custom-made large-diameter lens used for serious corneal surface damage or corneal deformation when standard treatments or rigid lenses have failed or cannot be used. It mainly affects ophthalmologists, specialist contact-lens practitioners, LAO, patients with severe corneal conditions, and reimbursement administrators. Coverage for both first fitting and renewal is extended until 31 December 2030, with follow-up checks every six months and lens replacement after a maximum of two years.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Renews reimbursement listing for LAO’s SPOT oxygen-permeable scleral lens until 31 December 2030
- Updates the covered medical indications, including severe corneal surface damage and certain corneal deformations
- Sets prescription, fitting, follow-up, and replacement conditions for reimbursed use
Obligations
What this law requires
Prescriptions for the SPOT oxygen-permeable scleral lens must be made by an ophthalmologist.
Fitting of SPOT scleral lenses must be carried out collaboratively by the prescribing ophthalmologist, an ophthalmologist specialized in contactology, and the manufacturer.
During fitting, a reusable trial lens must be provided and worn for no more than one hour.
Trial lenses must be destroyed if there is suspected contamination risk from transmissible subacute spongiform encephalopathy or another conventional infectious agent such as HIV, herpes, or adenovirus.
A transitional scleral lens must be manufactured and worn for 2 to 4 hours per day for one month to verify refraction, validate patient tolerance, and familiarize the patient with lens handling before definitive manufacture.